Business Description
Race Oncology Ltd
ISIN : AU000000RAC3
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -30.8 | |||||
3-Year EPS without NRI Growth Rate | -20.5 | |||||
3-Year FCF Growth Rate | -17.2 | |||||
3-Year Book Growth Rate | 4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.56 | |||||
9-Day RSI | 38.55 | |||||
14-Day RSI | 39.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.32 | |||||
Quick Ratio | 9.32 | |||||
Cash Ratio | 9.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.8 | |||||
Shareholder Yield % | -2.05 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -64.54 | |||||
ROA % | -61.02 | |||||
ROIC % | -405.51 | |||||
3-Year ROIIC % | 788.77 | |||||
ROC (Joel Greenblatt) % | -760.03 | |||||
ROCE % | -87.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 13.84 | |||||
Price-to-Tangible-Book | 17.6 | |||||
EV-to-EBIT | -12.74 | |||||
EV-to-EBITDA | -12.94 | |||||
EV-to-FCF | -24.9 | |||||
Price-to-Net-Current-Asset-Value | 17.6 | |||||
Price-to-Net-Cash | 17.6 | |||||
Earnings Yield (Greenblatt) % | -7.85 | |||||
FCF Yield % | -3.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Race Oncology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.03 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 39.53 | ||
14-Day ATR (€) | 0.021366 | ||
20-Day SMA (€) | 0.941 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 0.769 - 1.1014 | ||
Shares Outstanding (Mil) | 170.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Race Oncology Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Race Oncology Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Race Oncology Ltd Frequently Asked Questions
What is Race Oncology Ltd(FRA:FN3)'s stock price today?
When is next earnings date of Race Oncology Ltd(FRA:FN3)?
Does Race Oncology Ltd(FRA:FN3) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |